Bill S2386-2013

Enacts Aidan's law to require adrenoleukodystrophy screening of newborns

Enacts Aidan's law to require adrenoleukodystrophy screening of newborns.

Details

Actions

  • Feb 28, 2013: REPORTED AND COMMITTED TO FINANCE
  • Jan 17, 2013: REFERRED TO HEALTH

Meetings

Votes

VOTE: COMMITTEE VOTE: - Health - Feb 28, 2013
Ayes (16): Hannon, Farley, Felder, Fuschillo, Golden, Larkin, Savino, Seward, Young, Rivera, Montgomery, Sampson, Hassell-Thompson, Adams, Peralta, O'Brien
Nays (1): Ball

Memo

BILL NUMBER:S2386

TITLE OF BILL: An act to amend the public health law, in relation to requiring adrenoleukodystrophy screening of newborns

PURPOSE: Enacts Aidan's Law to require adrenoleukodystrophy screening of newborns

SUMMARY OF PROVISIONS: Section 1. This act shall be known and may be cited as "Aidan's Law". § 2. Subdivision (a) of section 2500-a of the public health law, as amended by chapter 863 of the laws of 1986, is amended to read as follows: (a) It shall be the duty of the administrative Officer or other person in charge of each institution caring for infants twenty-eight days or less of age and the person required in pursuance of the provisions of section forty-one hundred thirty of this chapter to register the birth of a child, to cause to have administered to every such infant or child in its or his care a test for phenylketonuria, homozygous sickle cell disease, hypothyroidism, branched-chain ketonuria, galactosemia, homocystinuria, adrenoleukodystrophy, and such other diseases and conditions as may from time to time be designated by the commissioner in accordance with rules or regulations prescribed by the commissioner. Testing, the recording of the results of such tests, tracking, follow-up reviews and educational activities shall be performed at such times and in such manner as may be prescribed by the commissioner. The commissioner shall promulgate regulations setting forth the manner in which information describing the purposes of the requirements of this section shall be disseminated to parents or a guardian of the infant tested.

JUSTIFICATION: Aidan Jack Seeger, was diagnosed with ALD (adrenoleukodystrophy) on June 2, 2011; he was just 6 years old. ALD is a horrific metabolic disease, which affects the myelin sheath in the brain and affects all neurological functioning, eventually leading to death. Aidan was in 1st grade, above grade level and running and playing as any other child his age. He started having vision problems around April and it was assumed he needed glasses.

After many doctors and finally an MRI and VLCFA blood test, Aidan was diagnosed with ALD. The only option to possibly stop the progression of the disease is a bone marrow transplant. Aidan received his unrelated cord blood transplant at Duke University in North Carolina on July 21, 2011, also his 7th birthday. The months that followed were grueling, the bone marrow transplant was a success, but unfortunately, since he was already symptomatic and with the effects of the chemotherapy and the disease progression, Aidan lost his ability to see, hear, eat, walk and communicate. After 10 months in the hospital, Aiden lost his battle with the disease on April 29, 2012.

If New York and the rest of the nation had newborn screening for ALD, Aidan and so many other children's prognosis would be different. Children who have undergone bone marrow transplants before the onset

of symptoms have had a much better prognosis and most are perfectly healthy today.

The urgency for these families to find out about this genetic disease at birth so they can be monitored and treated before symptoms arise is paramount. Unfortunately, many parents have never heard of this disease until diagnosed after the onset of symptoms. There are horror stories of the families that have had 1 child diagnosed, often too late for treatment, and then miracles, often bittersweet of brothers, cousins, etc. being tested after the tragedy, getting treatment and living full normal lives. We can save lives with a simple test.

PRIOR LEGISLATIVE HISTORY: None.

FISCAL IMPLICATIONS: To be determined.

LOCAL FISCAL IMPLICATIONS: To be determined.

EFFECTIVE DATE: This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediately the addition amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.


Text

STATE OF NEW YORK ________________________________________________________________________ 2386 2013-2014 Regular Sessions IN SENATE January 17, 2013 ___________
Introduced by Sen. ADAMS -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to requiring adreno- leukodystrophy screening of newborns THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. This act shall be known and may be cited as "Aidan's Law". S 2. Subdivision (a) of section 2500-a of the public health law, as amended by chapter 863 of the laws of 1986, is amended to read as follows: (a) It shall be the duty of the administrative officer or other person in charge of each institution caring for infants twenty-eight days or less of age and the person required in pursuance of the provisions of section forty-one hundred thirty of this chapter to register the birth of a child, to cause to have administered to every such infant or child in its or his care a test for phenylketonuria, homozygous sickle cell disease, hypothyroidism, branched-chain ketonuria, galactosemia, homo- cystinuria, ADRENOLEUKODYSTROPHY and such other diseases and conditions as may from time to time be designated by the commissioner in accordance with rules or regulations prescribed by the commissioner. Testing, the recording of the results of such tests, tracking, follow-up reviews and educational activities shall be performed at such times and in such manner as may be prescribed by the commissioner. The commissioner shall promulgate regulations setting forth the manner in which information describing the purposes of the requirements of this section shall be disseminated to parents or a guardian of the infant tested. S 3. This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediate- ly, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Discuss!

blog comments powered by Disqus